Administration of a dietary supplement (N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Many studies have found that N-oleyl-ethanolamine (NOE), a metabolite of N-oleyl-phosphatidylethanolamine (NOPE), and epigallocatechin-3-gallate (EGCG) inhibit food intake. The main aim of this study was to evaluate the efficacy of 2 months of administration of an oily NOPE–EGCG complex (85 mg NOPE and 50 mg EGCG per capsule) and its effect on compliance with diet in healthy, overweight people. Secondary end-points of the study were to compare body composition, metabolic parameters, sensation of appetite, depressive symptoms and severity of binge eating. Using a parallel-arm, double-blind, placebo-controlled design, 138 healthy, overweight women (106) and men (thirty-two) were randomly assigned to one of two groups: (1) the treatment group (seventy-one patients: fifty-three females, eighteen males) taking two capsules per day of an oral supplement or (2) the placebo group (sixty-seven patients: fifty-three females, fourteen males). Both groups observed a 3344 kJ/d energy restriction. All parameters were assessed both before onset and after 2 months on the supplement. Dropout was 6 % in the NOPE–EGCG group and 27 % in the placebo group (P < 0·001). The treatment induced a significant weight reduction in both groups ( − 3·28 kg and − 2·67 kg in NOPE–EGCG and placebo, respectively); the weight changes were not significantly different between the groups. NOPE–EGCG treatment improved insulin resistance (P < 0·001), the sensation feelings of fullness (P < 0·05), depressive symptoms (P < 0·004) and severity of binge eating (P < 0·0001).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 6×
“Insulin resistance was evaluated using the homeostasis model assessment (HOMA)(27) and the quantitative insulin sensitivity check index (QUICKI)(28) using the following formulas: HOMA¼ ðfastinginsulin;mU=mlÞ£ ðplasmaglucose;mmol=lÞ 22·5 ðnormalvalue : , 2·7Þ QUICKI¼ 1 logðglucose;mg=dlÞþ logðinsulin; mU=mlÞ ðnormalval…”
MethodInfluentialThe assessment of binge eating severity among obese persons
Gormally, J., Black, S., Daston, S., & Rardin, D. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90024-7 · Cited by 2,129
Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions
Higdon, J. V., & Frei, B. (2003) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690390826464 · Cited by 1,854 · cited 1×
“The catechin extracts from green tea, known for its antioxidant activity((7)), proved able to reduce excess cholesterol in the blood((8)), to improve insulin action((9)), to help control weight homeostasis((9)), to increase fat oxidation and thermogenesis((10)) and to reduce food intake((9)).”
BackgroundImpact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period
Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694 · cited 3×
“The likelihood of developing such conditions as type 2 diabetes, heart disease, cancer and osteoarthritis of weight-bearing joints increases as the body weight increases((1)), and these conditions lead to substantial economic costs for the overall health care budget.”
BackgroundMethodPretreatment predictors of attrition and successful weight management in women
Teixeira, P. J., Going, S. B., Houtkooper, L. B., Cussler, E. C., Metcalfe, L. L., Blew, R. M., Sardinha, L. B., & Lohman, T. G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802727 · Cited by 371 · cited 1×
“Many scientific works are now reconsidering the importance of evaluating what factors can affect compliance with a diet, and consequently the success of the treatment, both in terms of their ability to predict the results((5,6)) and during the course of the diet.”
Background
Cited by
Godos, J., Castellano, S., Ray, S., Grosso, G., & Galvano, F. (2018) · Molecules · doi:10.3390/molecules23050999 · Cited by 149
“Results from the present study are in line with intervention trials showing potential effects of cocoa- [31], berry- [32], citrus- [33], legume- and wine- [34], and tea-polyphenols [35] against depressive symptoms.”
ResultZheng, X.-X., Xu, Y.-L., Li, S.-H., Hui, R., Wu, Y.-J., & Huang, X.-H. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.032573 · Cited by 146
“Two studies were excluded because GTC was used as a multicomponent supplement in the experimental group, and the independent effects of GTCs could not be separated (53, 54).”
Strategies to reduce attrition in weight loss interventions: A systematic review and meta‐analysis
Pirotta, S., Joham, A., Hochberg, L., Moran, L., Lim, S., Hindle, A., & Brennan, L. (2019) · Obesity Reviews · doi:10.1111/obr.12914 · Cited by 45
“The overall risk of dropout following supplementation use could not be estimated through meta‐analysis as only two studies were included.(78,88)”
Background
Metadata
- Authors
- Rondanelli, M., Opizzi, A., Solerte, S. B., Trotti, R., Klersy, C., & Cazzola, R.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-07-01
- Volume
- 101
- Issue
- 3
- Pages
- 457-464
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W1980318506
- Cited by
- 44
- References
- 5
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Administration of a dietary supplement (N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial. https://app.cochat.ai/papers/10.1017/s0007114508024008
- The paper
- Rondanelli, M., Opizzi, A., Solerte, S. B., Trotti, R., Klersy, C., & Cazzola, R. (2008). Administration of a dietary supplement (N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial. British Journal of Nutrition. https://doi.org/10.1017/s0007114508024008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.